Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Curebase’s vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools, including all-in-one eClinical software and virtual research sites, designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.
Location: United States, California, San Francisco
Employees: 51-200
Total raised: $55M
Founded date: 2017
Investors 12
| Date | Name | Website |
| - | Mount Plea... | mountpleas... |
| 16.06.2021 | Synetro Gr... | synetro.co... |
| - | Bold Capit... | boldcapita... |
| 26.06.2022 | Breyer Cap... | breyercapi... |
| 26.04.2021 | Y Combinat... | ycombinato... |
| - | Xfund | xfund.com |
| - | C3 Venture... | c3.venture... |
| - | Positive S... | positivesu... |
| 10.12.2022 | GGV Capita... | ggvc.com |
| - | Notable Ca... | notablecap... |
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.05.2022 | Series B | $40M | - |
| 25.05.2021 | Series A | $15M | - |
Mentions in press and media 23
| Date | Title | Description |
| 22.12.2024 | The Digital Revolution in Healthcare: Monitoring Blood Pressure Remotely | In the age of technology, healthcare is undergoing a seismic shift. Digital platforms are becoming the backbone of patient monitoring. Closed Loop Medicine, a pioneer in this field, has unveiled a groundbreaking study that showcases the pot... |
| 17.12.2024 | Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring | Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use of the Company’s combined drug + digit... |
| 27.01.2023 | Curebase Launches Remote First DTx Research Platform | What You Should Know: This unique blend of eClinical software and technology-driven services enables sponsors of DTx studies to leverage the following Curebase capabilities: Technology and virtual site models: The company’s fit-for-purpose ... |
| 21.09.2022 | Meru Health recruits Curebase for mental health clinical trial | The companies are partnering on a 3 year long trial to measure the effectiveness of Meru's treatment There are many companies in the mental health space right now, all vying for dollars and attention, so all of them need to have some kind o... |
| 02.09.2022 | Medable rolls out new decentralized trial software for speedier vaccine development | Medable is arguably the strongest company in the decentralized clinical trials space. If fundraising is any measure of success, the company has raised more than $521 million since its founding in 2012 — significantly more than its competito... |
| 05.05.2022 | Sequoia, Andreessen Horowitz, a Saudi prince, and other investors have agreed to pour $7.1B into Elon Musk’s deal for Twitter | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. There’s nothing like a good SEC filing to wake a person up in the morning. Paid Content How does ... |
| 05.05.2022 | WIth the goal of expanding access to clinical trials, Curebase raises $40M | The company added Gilead as a strategic investor While all the ways that COVID affected healthcare remain to be seen, the system has already begun to respond to some of the inequities and inefficiencies that were exposed during the pandemic... |
| 05.05.2022 | Curebase thinks the future of clinical testing is decentralized, and raises $40M to prove it | The medical world has come a long way from the traditional, centralized way of conducting clinical trials, but there’s still a lot of modernization left to do. Curebase provides the infrastructure — physical and digital — for distributed cl... |
| 05.05.2022 | Curebase Raises $40M in Series B Funding | Curebase, a San Francisco, CA-based technology-driven clinical trial startup, raised $40m in Series B funding. The round was led by Industry Ventures, with participation from Acrew Capital, World Innovation Lab and Positive Sum, Gaingels, G... |
| 05.05.2022 | Clinical trial startup Curebase bags $40 million in Series B funding to democratize access to clinical studies | One of the lessons learned from the covid pandemic is how research institutions, governments, and pharmaceutical companies worked together to develop efficient vaccines to cure the deadly coronavirus. The pandemic is also a reminder of the ... |
Show more